Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Ibrutinib Therapy Downregulates Toso, the Fcr for IgM, Expression in CLL Patients

Mariela Sivina, Gordon Duncan, MSc, Takashi Sakamoto, MD PhD, Ekaterina Kim, MS, Alicia Vaca, PhD, Elena Maria Hartmann, MD, Michael J Keating, MBBS, Alessandra Ferrajoli, MD, William G. Wierda, MD PhD, Tak Mak, PhD DSc, Andreas Rosenwald, MD, Jan A. Burger, MD PhD

Blood (2019) 134 (Supplement_1): 5448.

https://doi.org/10.1182/blood-2019-125716

Published: 2019

Journal Articles

Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with T FH -like features and adverse clinical parameters

François Lemonnier, Lucile Couronné, Marie Parrens, Jean-Philippe Jaïs, Marion Travert, Laurence Lamant, Olivier Tournillac, Therese Rousset, Bettina Fabiani, Rob A. Cairns, Tak Mak, Christian Bastard, Olivier A. Bernard, Laurence de Leval, Philippe Gaulard

Blood (2012) 120 (7): 1466–1469.

https://doi.org/10.1182/blood-2012-02-408542

Published: 2012

Includes: Supplemental data

Journal Articles

Toso regulates the balance between apoptotic and nonapoptotic death receptor signaling by facilitating RIP1 ubiquitination

Xuan-Hung Nguyen, Philipp A. Lang, Karl S. Lang, Dieter Adam, Gulnar Fattakhova, Niko Föger, Mohammad Azhar Kamal, Patricia Prilla, Sabine Mathieu, Christina Wagner, Tak Mak, Andrew C. Chan, Kyeong-Hee Lee

Blood (2011) 118 (3): 598–608.

https://doi.org/10.1182/blood-2010-10-313643

Published: 2011

Includes: Supplemental data

Journal Articles

The ICOS:ICOSL Costimulatory Pathway Plays an Important Role in GVHD and Bone Marrow (BM) Graft Rejection.

Patricia Taylor, DVM, Angela Panoskaltsis-Mortari, PhD, Gordon Freeman, PhD, Arlene Sharpe, MD, PhD, Randolph Noelle, PhD, Alexander Rudensky, PhD, Tak Mak, MD, PhD, Jonathan Serody, MD, PhD, Bruce Blazar, MD

Blood (2004) 104 (11): 591.

https://doi.org/10.1182/blood.V104.11.591.591

Published: 2004

Journal Articles

MALT1 Is an Essential Regulator of Antigen Receptor Mediated NF-kappaB Activation.

Jürgen Ruland, MD, Tak Mak, PhD

Blood (2004) 104 (11): 347.

https://doi.org/10.1182/blood.V104.11.347.347

Published: 2004

NARROW

Ibrutinib Therapy Downregulates Toso, the Fcr for IgM, Expression in CLL Patients

Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with T FH -like features and adverse clinical parameters

Toso regulates the balance between apoptotic and nonapoptotic death receptor signaling by facilitating RIP1 ubiquitination

The ICOS:ICOSL Costimulatory Pathway Plays an Important Role in GVHD and Bone Marrow (BM) Graft Rejection.

MALT1 Is an Essential Regulator of Antigen Receptor Mediated NF-kappaB Activation.

Email alerts

ASH Publications

American Society of Hematology

Ibrutinib Therapy Downregulates Toso, the Fcr for IgM, Expression in CLL Patients

Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with T FH -like features and adverse clinical parameters

Toso regulates the balance between apoptotic and nonapoptotic death receptor signaling by facilitating RIP1 ubiquitination

The ICOS:ICOSL Costimulatory Pathway Plays an Important Role in GVHD and Bone Marrow (BM) Graft Rejection.

MALT1 Is an Essential Regulator of Antigen Receptor Mediated NF-kappaB Activation.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only